Renishaw plc (LON:RSW)‘s stock had its “sell” rating reissued by analysts at Deutsche Bank AG in a research report issued to clients and investors on Monday. They presently have a GBX 3,180 ($41.41) target price on the stock. Deutsche Bank AG’s price target suggests a potential downside of 28.33% from the company’s current price.
Other research analysts also recently issued research reports about the company. Numis Securities Ltd downgraded Renishaw plc to a “hold” rating and set a GBX 3,700 ($48.18) price objective on the stock. in a report on Wednesday, May 10th. Barclays PLC reiterated an “underweight” rating on shares of Renishaw plc in a report on Tuesday, April 25th. Two analysts have rated the stock with a sell rating and four have assigned a hold rating to the company. The company currently has an average rating of “Hold” and an average target price of GBX 3,420.60 ($44.54).
Renishaw plc (LON:RSW) opened at 4324.00 on Monday. The firm’s market cap is GBX 3.15 billion. Renishaw plc has a one year low of GBX 2,355.00 and a one year high of GBX 4,499.00. The firm has a 50-day moving average price of GBX 3,886.34 and a 200-day moving average price of GBX 3,417.42.
COPYRIGHT VIOLATION NOTICE: “Renishaw plc (RSW) Stock Rating Reaffirmed by Deutsche Bank AG” was first reported by BBNS and is the sole property of of BBNS. If you are viewing this news story on another domain, it was illegally copied and reposted in violation of U.S. and international copyright law. The legal version of this news story can be accessed at https://baseballnewssource.com/markets/renishaw-plc-rsw-stock-rating-reaffirmed-by-deutsche-bank-ag/1411688.html.
Renishaw plc Company Profile
Renishaw plc is a metrology company. The Company operates through two segments: metrology and healthcare. The Company’s metrology products are used in the fields of industrial automation and motion systems. The healthcare products include engineering solutions for stereotactic neurosurgery, diagnosis of infectious diseases, analytical tools that identify and characterize the chemistry and structure of materials, supply of implants to hospitals and specialist design centers for craniomaxillofacial surgery, and products and services that allow dental laboratories to manufacture dental restorations.
Receive News & Ratings for Renishaw plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renishaw plc and related companies with our FREE daily email newsletter.